70 Participants Needed

Superior Capsular Reconstruction vs. Partial Repair for Rotator Cuff Tears

(SCR Trial)

Recruiting at 1 trial location
PH
RA
Overseen ByRyan A Paul, MD, FRCSC
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Sunnybrook Health Sciences Centre
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests two surgical treatments for individuals with massive rotator cuff tears, which can cause significant shoulder pain and weakness. One group will undergo a newer method called superior capsular reconstruction (SCR), while the other will receive a standard procedure known as partial repair. The trial aims to determine which treatment is more effective and safer. Suitable candidates for this trial are those who have experienced shoulder pain or weakness due to large rotator cuff tears and have not found relief from at least three months of non-surgical treatments, such as physical therapy. As an unphased trial, this study offers participants the chance to contribute to valuable research that could enhance future treatment options.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What prior data suggests that these techniques are safe for treating rotator cuff tears?

Research shows that a new method called Superior Capsular Reconstruction (SCR) can reduce pain and improve shoulder movement after rotator cuff surgery. One study found that patients who underwent this procedure experienced less pain and better shoulder movement within two years. Another study reported pain relief and improved shoulder function two to four years post-surgery.

Partial repair, a well-known method for treating large rotator cuff tears, has been used for a long time and is considered a standard procedure. Studies have shown that it provides excellent results and high patient satisfaction, even 10 years after surgery.

Both treatments have been studied for their safety and effectiveness. SCR is newer but shows promising results, while partial repair has a proven track record over many years. Available data indicates no clear evidence of serious safety concerns for either treatment.12345

Why are researchers excited about this trial's treatments?

Researchers are excited about superior capsular reconstruction for rotator cuff tears because it offers a novel approach by using a dermal allograft to reconstruct the superior capsule of the shoulder. Unlike standard treatments like partial repair, which may leave a residual defect, this technique aims to provide more stability and function by effectively bridging the gap left by torn tendons. This could potentially improve shoulder mobility and reduce pain more effectively than conventional methods, offering hope for better long-term outcomes for patients with massive rotator cuff tears.

What evidence suggests that this trial's treatments could be effective for massive irreparable rotator cuff tears?

This trial will compare Superior Capsular Reconstruction (SCR) with Partial Repair (PRCR) for rotator cuff tears. Studies have shown that SCR effectively restores shoulder function and reduces pain in individuals with severe rotator cuff tears that cannot be repaired. Specifically, research indicates that patients over 65 experienced consistent improvements two years after undergoing SCR. In contrast, PRCR, a long-established standard treatment, has improved outcomes and reduced the chance of re-tearing, though the improvements might not be as significant as with more extensive repairs. Both treatments show promise, but the newer SCR technique may offer better long-term results for some patients.13467

Who Is on the Research Team?

PH

Patrick Henry, MD, FRCSC

Principal Investigator

Sunnybrook Health Sciences

Are You a Good Fit for This Trial?

This trial is for individuals who have massive rotator cuff tears larger than 4 cm, involving the supraspinatus and infraspinatus, that haven't improved after at least three months of non-surgical treatment. Participants must be experiencing shoulder pain or weakness but cannot have had previous surgery on the affected shoulder or certain conditions like advanced joint disease.

Inclusion Criteria

Informed consent obtained
My tear was found to be irreparable during surgery.
I have shoulder pain or weakness.
See 2 more

Exclusion Criteria

My shoulder's subscapularis muscle is either missing or cannot be repaired.
I have advanced shoulder damage due to a tear or arthritis.
I have had a tear injury within the last 6 months.
See 4 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks
1 visit (in-person)

Treatment

Participants undergo either superior capsular reconstruction or partial repair based on randomization

Surgery day
1 visit (in-person)

Postoperative Follow-up

Participants are monitored for safety and effectiveness with regular clinic visits

2 years
5 visits (in-person) at 6 weeks, 3 months, 6 months, 1 year, and 2 years post-surgery

What Are the Treatments Tested in This Trial?

Interventions

  • Partial Repair
  • Superior Capsular Reconstruction
Trial Overview The study compares two surgical techniques for treating massive irreparable rotator cuff tears: Superior Capsular Reconstruction (SCR) and Partial Rotator Cuff Repair (PRCR). It's a pilot randomized control trial to determine which method is more effective before conducting a larger clinical trial.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Superior Capsular ReconstructionExperimental Treatment1 Intervention
Group II: Partial RepairActive Control1 Intervention

Partial Repair is already approved in United States, European Union, Canada for the following indications:

🇺🇸
Approved in United States as Partial Rotator Cuff Repair for:
🇪🇺
Approved in European Union as Partial Rotator Cuff Repair for:
🇨🇦
Approved in Canada as Partial Rotator Cuff Repair for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

Sunnybrook Health Sciences Centre

Lead Sponsor

Trials
693
Recruited
1,569,000+

St. Joseph's Healthcare Hamilton

Collaborator

Trials
203
Recruited
26,900+

The Ottawa Hospital

Collaborator

Trials
97
Recruited
64,000+

Women's College Hospital

Collaborator

Trials
108
Recruited
43,700+

Published Research Related to This Trial

Limb-girdle muscular dystrophy type 2A (LGMD2A) is caused by mutations in the CAPN3 gene, leading to muscle fiber death and early clinical symptoms in specific muscle groups, but no clinical differences are observed based on mutation type.
Experimental therapies using adeno-associated virus (AAV) vectors show promise for gene transfer in LGMD2A, indicating a potential avenue for future treatments despite the lack of curative options currently.
Limb-girdle muscular dystrophy 2A.Gallardo, E., Saenz, A., Illa, I.[2021]
In a study involving 36 cadaveric specimens, the fixation method using three 3.5-mm knotless screw-in anchors demonstrated significantly greater load to failure compared to a 4-anchor hybrid technique, suggesting it provides better stability for superior capsular reconstruction (SCR) in patients with irreparable rotator cuff tears.
All fixation techniques showed similar graft elongation and stiffness, indicating that while the number of anchors may vary, the biomechanical performance in terms of elongation and stiffness remains consistent across methods.
Biomechanical Comparison of 3 Glenoid-Side Fixation Techniques for Superior Capsular Reconstruction.Pogorzelski, J., Muckenhirn, KJ., Mitchell, JJ., et al.[2019]
In a study of 93 unrelated families with limb-girdle muscular dystrophy type 2 (LGMD2), 29 families were identified with LGMD2A, and 22.6% of these had mutations in the CAPN3 gene, which is linked to this condition.
The researchers discovered six new mutations and confirmed nine previously reported mutations in the CAPN3 gene, suggesting that certain mutations are more common and could aid in diagnosing LGMD2A in Turkey.
Calpain-3 mutations in Turkey.Balci, B., Aurino, S., Haliloglu, G., et al.[2022]

Citations

Outcome of partial repair of massive rotator cuff tears with ...Our study has shown that allograft bridged repairs produce greater improvement in outcome scores at 2 years postoperatively compared to partial repair alone. It ...
Comparison between partial and full coverage repair in ...The purpose of this study was to compare re-tear rate and clinical outcome of arthroscopic repair of massive rotator cuff tears.
Improved clinical outcomes after arthroscopic partial rotator ...A retrospective review was conducted on arthroscopic rotator cuff repairs performed by a single surgeon between January 2018 and December 2022.
Arthroscopic Repair of Partial-Thickness Rotator Cuff Tears ...Editorial Commentary: Arthroscopic Repair of Partial-Thickness Rotator Cuff Tears Shows Long-Term Clinically Significant Improved Outcomes.
Superior Capsular Reconstruction vs. Partial Repair for ...Arthroscopic partial rotator cuff repair (PRCR) is arguably the gold-standard surgical option with the longest record of use. The new technique ...
6.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/37306068/
Minimum 10-Year Outcomes After Arthroscopic Repair of ...Arthroscopic repair of PTRCTs results in excellent clinical outcomes and high patient satisfaction at minimum 10-year follow-up.
Biologically Enhanced Repair of Interstitial Rotator Cuff ...Arthroscopic repair of interstitial tears by first completing the tear yielded improved clinical outcomes including pain and function but showed a retear rate ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security